Page 27 of articles about antimicrobial

The Plan is designed to guide action by public health, healthcare, and veterinary partners in a common effort to address urgent and serious drug-resistant threats that affect people in the U.S. and around the world.

Multi-drug resistant isolates of Salmonella continue to spread across Europe. Also, high resistance to the antimicrobial ciprofloxacin in Campylobacter isolates has been reported in some Member States.

Comparison of antimicrobial consumption data in animals and humans in 2012 revealed that overall antimicrobial consumption was higher in animals than in humans, although contrasting situations were observed between countries.

Vision 2020 Plan sets the goal of a "50% reduction in the use of veterinary antibiotics by 2020".

The percentage of meticillin-resistant Staphylococcus aureus (MRSA) showed a significant decreasing trend at EU/EEA level for the period 2010 to 2013, but the decrease was less pronounced compared to the previous four-year period.

Between 2012 and 2013, the exposure to antibiotics fell by 6.6% in cattle, by 5.4% in fowl, by 4% in pigs and by 1.7% in pets.

The Association of Public and Land-grant Universities (APLU) and the Association of American Veterinary Medical Colleges (AAVMC) announced the creation of the Task Force on Antibiotic Resistance in Production Agriculture.

Antimicrobial consumption in pigs measured in doses has increased in all three age groups.

WHO has published its first draft of a global action plan to tackle antimicrobial resistance.

The total quantity of medically important antimicrobials sold or distributed for use in food-producing animals increased by 16 percent over the period 2009-2012.

Detecting, preventing and controlling antibiotic resistance requires a coordinated effort.